Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.27 | 32.50 |
| PEG Ratio (TTM) | -0.31 | 5.87 |
| P/S Ratio (TTM) | 0.29 | 5.17 |
| P/B Ratio (TTM) | 1.66 | 9.42 |
| P/FCF Ratio (TTM) | -19.29 | 24.17 |
| Price to 5YR AVG Earnings Ratio | 190.95 | 33.57 |
| Price to 5YR AVG FCF Ratio | 23.02 | 75.53 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.27% | 5.42% |
| ROE (TTM) | -41.13% | 21.15% |
| Net Profit Margin (TTM) | -8.76% | -28.14% |
| ROIC 5YR AVG | 3.97% | 91.95% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -27.88% | 103.04% | -52.85% |
| Revenue | 0.12% | 37.77% | 18.52% |
| Net Income | -27.48% | 106.58% | -55.61% |
| Cash Flow | -408.20% | 101.39% | -392.76% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.49 | 1.99 |
| Quick Ratio (TTM) | 0.93 | 1.45 |
| D/E Ratio (TTM) | 0.79 | 1.29 |
| Interest Coverage (TTM) | -6.26 | 16.89 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 4.36 |
| LTL to 5YR AVG FCF | 9.72 | 6.35 |
| Shares Outstanding Growth 5YR AVG | 2.29% | 11.16% |